Baystreet.ca News Commentary – The healthcare industry is undergoing a major digital shift, with leaders betting heavily on ...

The US Food and Drug Administration (FDA) has accepted Novo Nordisk’s new drug application (NDA) submission for the 25 mg ...

The Danish drugmaker is expanding Wegovy access via telehealth providers like Hims and Ro. But the gap with Eli Lilly is only ...

Novo Nordisk has launched its hugely popular weight-loss drug Wegovy in Thailand, an executive of the Danish drugmaker's ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Doctors have explained the potential pros and cons of these so-called 'skinny jabs', with everything from nausea to abdominal ...

Pharmaceutical company Novo Nordisk will expand its production site in Montes Claros, Brazil, creating 600 jobs.

Brazil, which hosts this year's United Nations climate summit, has a main goal of persuading Europe, China and other ...

Researchers have added to fears around the drug, however, after calling for ‘urgent attention’ following a discovery that ...

Financial giants have made a conspicuous bullish move on Novo Nordisk. Our analysis of options history for Novo Nordisk (NYSE:NVO) revealed 15 unusual trades. Delving into the details, we found 46 ...

Novo Nordisk (NYSE: NVO), the Danish drugmaker that's been riding high ever since it began putting out Ozempic and Wegovy GLP-1 injectables for treatment of diabetes and weight loss, got another ...

Novo Nordisk A/S (NYSE:NVO ... it announced an investment of just over one billion dollars in Brazil in a bid to boost the production of both Wegovy and Ozempic. Brazil is a major manufacturing ...